Ben Phillips, Chief Investment Officer at EventShares, a financial firm that creates ETFs based on political and other events, discusses the company's latest fund focused on the tax reform bill.
For each ETF, EventShares chooses stocks that stand to benefit based on the policies put forth by each party. The tax reform ETF functions the same way. Phillips adds that EventShares has the ability to re-balance the ETF as needed, based on the conversation coming out of Washington.
We talk about how the reform bill will impact indexes as a whole, but Phillips adds that he does not think that investing in specific indices is the way to go. He believes that investors can profit the most off of tax reform through an ETF with carefully curated companies.
Walmart, which became the nation’s largest retailer by making low prices a priority, has found itself in a place it’s rarely been: Warning customers that prices will rise for goods ranging from bananas to car seats.
Chris Beauchamp, Chief Market Analyst at IG International, joins J.D. Durkin to give analysis on the recent trade truce between the U.S. and China. Watch!
Shan Aggarwal, VP of Corporate and Business Development at Coinbase, discusses the company's acquisitio of Deribit as it heads into the S&P 500. Watch!
American businesses that rely on Chinese goods are reacting with muted relief after the U.S. and China agreed to pause their exorbitant tariffs on each other’s products for 90 days. Many companies delayed or canceled orders after President Donald Trump last month put a 145% tariff on items made in China. Importers still face relatively high tariffs, however, as well as uncertainty over what will happen in the coming weeks and months. The temporary truce was announced as retailers and their suppliers are looking to finalize their plans and orders for the holiday shopping season. They’re concerned a mad scramble to get goods onto ships will lead to bottlenecks and increased shipping costs.
Shopping expert Trae Bodge discusses how talks between the U.S. and China is good news for now, but uncertainty remains for back-to-school and the holidays.
Jake Traylor, White House reporter at Politico, joins Cheddar to discuss how Trump is aiming to lower drug prices and how it differs from Biden's approach.
